SBRT for early-stage glottic larynx cancer—Initial clinical outcomes from a phase I clinical trial
Sign Up to like & getrecommendations! Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0172055
Abstract: Purpose To confirm safety and feasibility of hypofractionated SBRT for early-stage glottic laryngeal cancer. Methods Twenty consecutive patients with cTis-T2N0M0 carcinoma of glottic larynx were enrolled. Patients entered dose-fractionation cohorts of incrementally shorter bio-equivalent schedules… read more here.
Keywords: early stage; cancer; sbrt early; stage glottic ... See more keywords